Page 52 - Use Authorization News Today

S.D. reaches vaccination milestone – Half of state’s adult population fully vaccinated against COVID-19 By Todd Epp PIERRE, S.D. (KELO.com) – Wednesday, the South Dakota Department of Health announced that the adult population of residents who are fully vaccinated against COVID-19 has reached the 50% threshold or over 304,435 South Dakotans having completed their full vaccine series. Emergency Use Authorization of the Pfizer vaccine from the Centers for Disease Control a...

CVS will begin administering Pfizers Covid-19 vaccine in 12-15-year-olds on Thursday From CNN’s Virginia Langmaid CVS pharmacies will begin to administer Pfizer’s Covid-19 vaccine to children ages 12-15 on Thursday, the company said Wednesday. The US Centers for Disease Control and Prevention’s Advisory Committee on Immunization Practices recommended the vaccine in this age group on Wednesday. The vaccine will be available for children 12-15 starting on Thursday in more than 5,600 locatio...

BRHD Town Hall Thursday afternoon with two pediatricians Photo: WINA CHARLOTTESVILLE (WINA) – The Blue Ridge Health District is doing its first virtual Town Hall in awhile to update everyone on a number of developments in the pandemic, and about vaccinations. Since their last Town Hall, vaccine supplies have become more abundant and walk-ins have begun to be accepted at the JC Penney location, and at Seminole Square where BRHD operates jointly with UVa Health. Albemarle County Executive Jef...

Share this article Share this article MONMOUTH JUNCTION, N.J., May 11, 2021 /PRNewswire/ -- CytoSorbents Corporation (NASDAQ: CTSO), a critical care leader commercializing its CytoSorb® and other blood purification technologies to treat deadly conditions in critically-ill and cardiac surgery patients around the world, announced the U.S Army Medical Research and Development Command has awarded CytoSorbents a Defense Health Agency (DHA) Sequential Phase II Small Business Innovation Research (S...

What is the difference between emergency-use authorization and full FDA approval for COVID-19 vaccines? For instance, businesses will be able to legally require employees be vaccinated once the FDA gives its full approval. Author: Monica Robins Updated: 12:32 PM EDT May 13, 2021 CLEVELAND — So far only one vaccine maker has submitted for full approval from the Food and Drug Administration (FDA), but the other two are not far behind. But the question many are wo...

Press release content from Globe Newswire. The AP news staff was not involved in its creation. BioNTech Announces First Quarter 2021 Financial Results and Corporate Update BioNTech SEMay 10, 2021 GMT More than 450 million doses of BNT162b2 supplied to 91 countries or territories worldwide as of May 6, 2021 Signed agreements for over 1.8 billion doses of BNT162b2 in 2021 and first contracts signed for periods 2022 and beyond Announced planned expansion of global footprint to Asia with establishm...

BioNTech SE: BioNTech Announces First Quarter 2021 Financial Results and Corporate Update More than 450 million doses of BNT162b2 supplied to 91 countries or territories worldwide as of May 6, 2021 Signed agreements for over 1.8 billion doses of BNT162b2 in 2021 and first contracts signed for periods 2022 and beyond Announced planned expansion of global footprint to Asia with establishment of first regional headquarters for south east Asia in Singapore, including a fully-integrated and state-o...

Author Bio Keith began writing for the Fool in 2012 and focuses primarily on healthcare investing topics. His background includes serving in management and consulting for the healthcare technology, health insurance, medical device, and pharmacy benefits management industries. Follow @keithspeights What happened Shares of Ocugen (NASDAQ:OCGN) were tanking by 12.7% as of 11:16 a.m. EDT on Friday after falling as much as 20.6% earlier in the day. The big decline came after...

and Variant Neutralization Results — In April 2021, Ocugen announced that its co-development partner, Bharat Biotech International Limited ("Bharat Biotech"), shared positive results from the second interim analysis of its Phase 3 clinical trial of COVAXIN showing 78% overall efficacy against COVID-19 disease, 100% efficacy against severe COVID-19 disease (including hospitalization), and 70% efficacy against asymptomatic COVID-19 infection, indicating the potential to significantly reduce vi...

Milwaukee Health Department planning Pfizer distribution for kids 12-15, amid survey showing most parents hesitant   To view this video please enable JavaScript, and consider upgrading to a web browser that supports HTML5 video NOW: Milwaukee Health Department planning Pfizer distribution for kids 12-15, amid survey showing most parents hesitant NEXT: ); if(!WVM.IS_S...